186 related articles for article (PubMed ID: 20092222)
1. Warfarin versus aspirin: using CHADS2 to guide therapy for stroke prevention in nonvalvular atrial fibrillation.
Hopps S; Marcy TR
Consult Pharm; 2009 Nov; 24(11):841-4. PubMed ID: 20092222
[TBL] [Abstract][Full Text] [Related]
2. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
4. Warfarin and Aspirin Use for Stroke Prevention Among Patients With Atrial Fibrillation: The US National Health and Wellness Survey.
Goren A; Liu X; Gupta S; Simon TA; Phatak H
Am J Ther; 2015; 22(4):248-56. PubMed ID: 24326696
[TBL] [Abstract][Full Text] [Related]
5. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
[TBL] [Abstract][Full Text] [Related]
6. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
7. A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study.
Azoulay L; Dell'Aniello S; Simon TA; Langleben D; Renoux C; Suissa S
BMC Cardiovasc Disord; 2012 Jun; 12():49. PubMed ID: 22734842
[TBL] [Abstract][Full Text] [Related]
8. Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.
Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):585-99. PubMed ID: 26725259
[TBL] [Abstract][Full Text] [Related]
9. Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.
Athanasakis K; Boubouchairopoulou N; Karampli E; Tarantilis F; Savvari P; Bilitou A; Kyriopoulos J
Am J Cardiovasc Drugs; 2017 Apr; 17(2):123-133. PubMed ID: 27882517
[TBL] [Abstract][Full Text] [Related]
10. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.
Hart RG; Pearce LA; Miller VT; Anderson DC; Rothrock JF; Albers GW; Nasco E
Cerebrovasc Dis; 2000; 10(1):39-43. PubMed ID: 10629345
[TBL] [Abstract][Full Text] [Related]
11. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation.
Deguchi I; Ogawa H; Ohe Y; Nemoto M; Tanahashi N
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):846-50. PubMed ID: 22819543
[TBL] [Abstract][Full Text] [Related]
12. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
Gage BF; van Walraven C; Pearce L; Hart RG; Koudstaal PJ; Boode BS; Petersen P
Circulation; 2004 Oct; 110(16):2287-92. PubMed ID: 15477396
[TBL] [Abstract][Full Text] [Related]
13. Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice.
An J; Niu F; Lang DT; Jazdzewski KP; Le PT; Rashid N; Meissner B; Mendes R; Dills DG; Aranda G; Bruno A
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26187996
[TBL] [Abstract][Full Text] [Related]
14. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for stroke prevention in patients with atrial fibrillation.
Howard PA
Drugs; 1999 Dec; 58(6):997-1009. PubMed ID: 10651387
[TBL] [Abstract][Full Text] [Related]
16. Incidental atrial fibrillation and its management.
Saliba W
Postgrad Med; 2011 Mar; 123(2):27-35. PubMed ID: 21474890
[TBL] [Abstract][Full Text] [Related]
17. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
18. What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?
Lip GY
J R Coll Physicians Edinb; 2012; 42 Suppl 18():35-44. PubMed ID: 22518392
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?
Wong CW
Hong Kong Med J; 2016 Dec; 22(6):608-15. PubMed ID: 27920399
[TBL] [Abstract][Full Text] [Related]
20. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
